Publications | Functional Fluidics

Natalizumab Blocks Adhesion of Sickle Cell Whole Blood Cells to Activated Endothelial Cells under Flow Conditions.

Written by John C | Sep 26, 2014

Wayne State University School of Medicine

White JC: